Condition

Dry Eye Syndromes

ClinicalTrials.gov condition label

Clinical trials19
Recruiting1
Common interventions24
Lead sponsors shown15

Clinical trials

19 shown
Clinical Applications of Advanced Ophthalmic ImagingNCT03135327 · 2007-01-01
RECRUITING
Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic PatientsNCT07810569 · 2026-10-01
NOT_YET_RECRUITING
Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry EyeNCT06543667 · 2024-08-01
UNKNOWN
Dual-Polymer Hydroxypropyl Guar-and Hyaluronic Acid Lubricants in Rheumatoid ArthritisNCT06209879 · 2024-02-05
UNKNOWN
Salivary Conductivity Screening for Dry Eye Disease and Sjögren's SyndromeNCT06406933 · 2023-07-01
UNKNOWN
Effect of Topical Antioxidants in Dry Eye Disease and Diabetic RetinopathyNCT05429229 · 2021-11-01
UNKNOWN
CEQUA for Sjogren's Syndrome Dry EyeNCT04835623 · 2021-06-21
COMPLETED
Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry EyeNCT04493658 · 2021-01-11
COMPLETED
Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE FittingNCT04649177 · 2020-12-15
COMPLETED
Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye DiseaseNCT04143841 · 2019-10-30
TERMINATED
The Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyaluronate 0.1% Eye Drop to Tear Film Stability and Conjunctival Goblet Cells Density in Patient With Non-Proliferative Diabetic Retinopathy (NPDR), and Proliferative Diabetic Retinopathy (PDR)NCT04000789 · 2019-07-01
UNKNOWN
TrueTear in Sjogren's Disease PatientsNCT03719885 · 2018-12-01
COMPLETED
Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry EyeNCT03012698 · 2017-11-01
COMPLETED
Comparison Between Rebamipide 2% Versus Autologous SerumNCT03608761 · 2017-02-06
COMPLETED
0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic PatientsNCT02595606 · 2015-09-01
UNKNOWN
Effects of Sustained Reading on the Ocular SurfaceNCT02031172 · 2014-03-01
TERMINATED
A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren SyndromeNCT02011776 · 2013-03-01
COMPLETED
Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid ArthritisNCT02252744 · 2012-11-01
COMPLETED
Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency VirusNCT00797030 · 2006-10-01
UNKNOWN

Common interventions

0.3% Sodium HyaluronateDRUG1autologous serumBIOLOGICAL1autologous serum and rebamipide 2%OTHER1Carbomer Gel/JellyDRUG1Cyclosporine 0.09% Ophthalmic SolutionDRUG1cyclosporine and sodium carboximethycelluloseDRUG1Humylub PF®DRUG1Impression CytologyDIAGNOSTIC_TEST1Lagricel PF®DRUG1Limbal Stem Cell Derived Exosomes Eye DropBIOLOGICAL1No interventionOTHER1OcufolinDIETARY_SUPPLEMENT1Ocular Repetitive Magnetic Stimulation (RMS) treatmentDEVICE1Ocular surface optical coherence tomographyDEVICE1QuestionnairesDIAGNOSTIC_TEST1RebamipideDRUG1sodium carboximethycelluloseDRUG1Sodium Hyaluronate, Vitamin A, Vitamin EDRUG1SYSTANE™ Hydration Lubricant Eye DropsDRUG1Tear fluid samplingDIAGNOSTIC_TEST1TrueTear Intranasal Tear NeurostimulatorDEVICE1VisuXL®DRUG1Viveye OMNS sham treatmentDEVICE1Viveye OMNS treatmentDEVICE1

Trial status mix

COMPLETED8
UNKNOWN7
TERMINATED2
NOT_YET_RECRUITING1
RECRUITING1

Phase mix

NA6
PHASE45
PHASE11
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.